Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

83
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
83
Drug Delivery: Overview01:16

Drug Delivery: Overview

1.1K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.1K
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

104
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
104
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

74
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
74
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

179
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
179
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

83
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
83

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-Time 3D Reconstruction of Nanomotor Dynamics Using Phase-Space Deconvolution Light-Field Microscopy.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

The 'sugar' side of extracellular vesicle-glycome: a panorama from basic characteristics, deciphering technologies, functions, to applications.

Journal of nanobiotechnology·2026
Same author

Bio-Propelled Stomatocyte Nanomotors with Glutathione-Responsiveness for Osteoarthritis Treatment.

Angewandte Chemie (International ed. in English)·2026
Same author

Reconfiguration of Multiphase Coacervate Droplets Into Self-Regulated Nested Artificial Cells.

Angewandte Chemie (International ed. in English)·2026
Same author

Droplet-Based Facile Deciphering of Heterogeneous Glycans in Extracellular Vesicles down to the Single-Particle Level.

Analytical chemistry·2026
Same author

Cooperative Rotation of Multiple F<sub>o</sub>F<sub>1</sub>-ATPase Motors in a Janus Photophosphorylation Nanobot.

Small (Weinheim an der Bergstrasse, Germany)·2026

Related Experiment Video

Updated: Mar 20, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.7K

Bioinspired Platform Conjugated Active Drug Delivery.

Jingxin Shao1,2, Mingjun Xuan1,3, Qiang He1

  • 1Key Laboratory of Micro-systems and Micro-structure Manufacturing, Ministry of Education, MicroNanotechnology Research Centre, Harbin Institute of Technology, Harbin, China.

Current Drug Targets
|June 6, 2016
PubMed
Summary

Advancements in nanotechnology and biotechnology are revolutionizing targeted drug delivery systems. This review highlights active drug delivery methods like molecular motors and nanomotors for improved therapeutic applications.

Keywords:
Bioinspiredactive targetingbio-camouflagedrug deliverymolecular motorself-propelled nanomotors.

More Related Videos

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

8.1K
Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

9.1K

Related Experiment Videos

Last Updated: Mar 20, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.7K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

8.1K
Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

9.1K

Area of Science:

  • Biotechnology and Nanotechnology
  • Biomedical Engineering
  • Drug Delivery Systems

Background:

  • Nanotechnology and biotechnology have driven significant advancements in drug delivery systems.
  • Drug delivery research focuses on enhancing carrier functions and applications.
  • Active drug delivery offers targeted transport within biological systems.

Purpose of the Study:

  • To summarize active targeted cargo-mediated drug delivery patterns.
  • To introduce active targeted carriers and discuss their binding capabilities.
  • To detail the mechanisms of active targeted transport in drug delivery.

Main Methods:

  • Review of existing literature on active drug delivery systems.
  • Categorization of delivery patterns including molecular motors, bio-camouflaged particles, and self-propelled nanomotors.
  • Analysis of the mechanisms and applications of active targeted carriers.

Main Results:

  • Several active drug delivery patterns were summarized, showcasing innovative approaches.
  • Active targeted carriers, including molecular motors and nanomotors, demonstrate enhanced binding capabilities.
  • The mechanisms underlying active targeted transport were elucidated, highlighting their potential.

Conclusions:

  • Active drug delivery systems represent a promising frontier in medicine.
  • Molecular motors, bio-camouflaged particles, and nanomotors are key innovations in targeted drug delivery.
  • Further research into active targeted transport mechanisms will optimize therapeutic outcomes.